Search

everythinglearnresearchcommunity

for

Search:↓

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Finasteride reduces hair growth and is safe for women with excessive hair.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.